Centre for Health Behaviours Research, JC School of Public Health and Primary Care, The Chinese University of Hong Kong , Hong Kong, China.
Shenzhen Research Institute, The Chinese University of Hong Kong , Shenzhen, China.
Hum Vaccin Immunother. 2021 Feb 1;17(2):527-536. doi: 10.1080/21645515.2020.1776545. Epub 2020 Jul 2.
Individuals aged ≥65 y are recommended to receive pneumococcal vaccination (PV). PV completion is defined as receiving two doses of PV among those with at least one high-risk condition for severe invasive pneumococcal diseases (IPD) or receiving one dose of PV among those without any high-risk conditions. This study investigated factors associated with PV completion among a random sample of community-living older adults in Hong Kong, China. In addition, factors associated with receiving a single dose of PV among older adults with at least one high-risk condition were also investigated. A total of 750 community-living Chinese-speaking individuals aged ≥65 y in Hong Kong (response rate: 63.4%) completed a random telephone survey from May to July 2019. PV completion was 10% among all participants. Among participants with high-risk condition(s) for severe IPD, 11.4% received a single dose of PV. After adjustment for significant background variables, several Health Belief Model constructs were significantly associated with both dependent variables: (1) perceived risk of contracting pneumococcal diseases, (2) perceived benefits of PV for protecting themselves or others, (3) perceived barriers to PV uptake, (4) being suggested by significant others to take up PV (cue to action), and (5) confidence to take up PV (perceived self-efficacy). In addition, being knowledgeable about pneumococcal diseases and vaccination, and knowing at least one peer of similar age who had taken up PV were also positively associated with both dependent variables. Targeted, theory-based health promotion efforts are needed to increase PV coverage among elderly in Hong Kong.
建议年龄≥65 岁的个体接种肺炎球菌疫苗(PV)。PV 完成定义为:在至少有一种严重侵袭性肺炎球菌病(IPD)高危因素的人群中接种两剂 PV,或在无任何高危因素的人群中接种一剂 PV。本研究调查了中国香港社区居住的老年人群中,与 PV 完成相关的因素。此外,还调查了在至少有一种高危因素的老年人群中接受一剂 PV 的相关因素。2019 年 5 月至 7 月,香港共有 750 名年龄≥65 岁的社区居住的讲中文的个体(应答率:63.4%)完成了一项随机电话调查。所有参与者中,PV 完成率为 10%。在有严重 IPD 高危因素的参与者中,11.4%接受了一剂 PV。在调整了显著的背景变量后,几个健康信念模型结构与两个因变量均显著相关:(1)罹患肺炎球菌病的风险感知,(2)PV 保护自己或他人的获益感知,(3)PV 接种的障碍感知,(4)重要他人建议接种 PV(行动提示),以及(5)接种 PV 的信心(感知自我效能)。此外,了解肺炎球菌病和疫苗接种,以及认识至少一位年龄相仿的已接种 PV 的同龄人,也与两个因变量均呈正相关。需要有针对性的、基于理论的健康促进措施,以提高香港老年人的 PV 覆盖率。